Latest News about Pharmaceuticals
Recent news which mentions Pharmaceuticals
4 Undervalued Stocks To Watch For In April
Today 11:43 EDT
From Benzinga
Tickers
OIL
From CNBC.com News
The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight
April 10, 2021
From Benzinga
From Business Journals
From CNBC.com News
Thermo Fisher CEO made $26.4M last year, up $39% over 2019
April 08, 2021
From Business Journals
From CNBC.com News
The Petri Dish: Former bluebird CMO lands at Tessera, Moderna to collaborate on HIV vaccine
April 08, 2021
From Business Journals
From Business Journals
Ahead of the Olympics, Japan's vaccine minister says virus situation in Tokyo could worsen
April 08, 2021
From CNBC.com News
From CNBC.com News
Vaccines are a national priority but not 'silver bullets' for reopening, Singapore minister says
April 06, 2021
From CNBC.com News
After FDA Rejects Acadia Dementia Drug, Analysts Lament Lack Of Near-term Stock Drivers
April 06, 2021
Tickers
ACAD
From Benzinga
Main Line biotech firm raises $40M in Series A round to advance new high blood pressure treatment
April 06, 2021
From Business Journals
From Business Journals
The Week Ahead In Biotech: Regeneron, Supernus FDA Decisions, Cancer Conference Presentations In The Spotlight
April 03, 2021
From Benzinga
CEO: Iqvia's Q2 deal means jobs in the Triangle
April 02, 2021
From Business Journals
MIT's Koch Institute gets new director
March 31, 2021
From Business Journals
From Business Journals
66 Biggest Movers From Yesterday
March 31, 2021
From Benzinga
41 Stocks Moving In Tuesday's Mid-Day Session
March 30, 2021
From Benzinga
33 Stocks Moving in Tuesday's Pre-Market Session
March 30, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.